EA
LAB icon

Emerald Acquisition’s Standard BioTools LAB Stock Holding History

Emerald Acquisition’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$13.6M Buy
1,698,654
+256,837
+18% +$2.36M 0.03% 707
2016
Q2 		$13M Buy
+1,441,817
New +$13.6M 0.02% 802

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Emerald Acquisition's LAB Position: Q3 2016 in Review

Emerald Acquisition increased its Standard BioTools (LAB) stake by 18% in Q3 2016, buying an estimated $2.36M and bringing the position to 1,698,654 shares worth $13.6M. The position accounts for 0.03% of the portfolio, ranked #707.

Emerald Acquisition first reported a position in LAB in Q2 2016 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold LAB as of Q3 2016.

  • Emerald Acquisition held 1,698,654 shares of Standard BioTools worth $13.6M as of Q3 2016.
  • Emerald Acquisition bought 256,837 Standard BioTools shares in Q3 2016, an estimated $2.36M.
  • Standard BioTools made up 0.03% of Emerald Acquisition's portfolio in Q3 2016, its #707 holding.
  • Emerald Acquisition first reported a position in Standard BioTools in Q2 2016 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.